Opioids
The Department of Health and Human Services this week awarded $487 million in fiscal year 2019 grants to help states and territories increase access to medication-assisted treatment for opioid use disorder and reduce opioid overdose deaths.
The three medications approved by the Food and Drug Administration to treat opioid use disorder — methadone, buprenorphine and extended-release naltrexone — are effective and save lives, but most people who could benefit from these treatments do not receive them, according to a report released…
In a study of Blue Cross and Blue Shield enrollees reported last week in the New England Journal of Medicine, initial opioid prescriptions declined 54 percent between July 2012 and December 2017.
The House Energy and Commerce Health Subcommittee today held a hearing on the president’s fiscal year 2020 budget request for the Department of Health and Human Services.
March 12 at 2PM ET
Join the AHA's Section for Psychiatric & Substance Abuse Services and AHA’s Physician Alliance on March 12 at 2 p.m. ET for a webinar on the Prescribe Safe Initiative.
Eligible organizations can apply through May 6 for up to $1 million each for a three-year period to expand opioid and other substance use disorder services in high-risk rural communities.
Birmingham VA Medical Center’s weekly, 90-minute shared medical appointments help veterans address opioid reliance.
The Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies today held a hearing to review what programs and strategies are working to address the opioid epidemic and where to focus future funding.
Food and Drug Administration Commissioner Scott Gottlieb, M.D., yesterday announced the agency’s 2019 agenda to address the opioid epidemic.
The Centers for Medicare & Medicaid Services today released an updated tool for viewing and comparing opioid prescribing rates over time and across regions.